Related Experiment Video
Updated: May 28, 2026

05:21
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Influenza 2011-2012: What has changed?
1University of Maryland School of Nursing, Baltimore, Md, USA.
The Nurse Practitioner
|October 20, 2011
Summary
The 2011-2012 flu season follows the novel H1N1 pandemic. This review covers H1N1 signs, symptoms, high-risk groups, and CDC immunization guidelines.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- The United States experienced a novel H1N1 influenza pandemic during the 2009-2010 season.
- Recovery from this pandemic impacts preparedness for subsequent influenza seasons.
Purpose of the Study:
- To review key aspects of the 2011-2012 influenza season in the context of the recent H1N1 pandemic.
- To provide updated information on H1N1 influenza, including clinical presentation and prevention strategies.
Main Methods:
- Review of current literature and guidelines.
- Synthesis of information regarding H1N1 influenza.
- Analysis of Centers for Disease Control and Prevention (CDC) recommendations.
Main Results:
- The 2011-2012 influenza season occurs during ongoing recovery from the 2009-2010 H1N1 pandemic.
- Information on H1N1 signs and symptoms is crucial for early detection.
- Identification of high-risk groups is essential for targeted interventions.
- Updated immunization recommendations and CDC guidelines are provided.
Conclusions:
- Preparedness for the 2011-2012 influenza season requires consideration of the H1N1 pandemic's impact.
- Adherence to CDC guidelines and vaccination recommendations is vital for public health protection.
- Understanding H1N1 characteristics aids in managing seasonal influenza effectively.
Related Concept Videos
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccinations
Overview
Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...

